DUBLIN--(BUSINESS WIRE)--The "Leukapheresis Market by Product, Leukopak, Application, End User - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The leukapheresis products market is expected to reach USD 27.7 million by 2023 from an estimated USD 19.4 million in 2018, at a CAGR of 7.4%.
The leukopaks market is expected to reach USD 445.6 million by 2023, at a CAGR of 46.4%. Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes. The increasing incidence and prevalence of leukemia and growing demand for leukopaks for research applications are some of the factors driving the growth of these markets. However, the high cost of therapeutic leukapheresis and leukopaks and stringent donor recruitment criteria are restraining the growth of this market to a certain extent.
By type, the leukapheresis products market is segmented into leukapheresis devices and leukapheresis disposables. The leukapheresis devices segment is further subsegmented into apheresis devices, leukapheresis columns & cell separators, and leukoreduction filters. The leukoreduction filters segment is expected to register the highest CAGR during the forecast period. This high growth-rate can be attributed to the increasing adoption of leukoreduction filters by researchers.
On the basis of type, the leukopaks market is segmented into mobilized leukopaks, non-mobilized leukopaks, diseased leukopaks, and isolated PBMCs. The isolated PBMCs segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the increasing focus of researchers on cell-based therapies including CAR-T therapy targeted development.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Leukapheresis Products Market, By Type
8 Leukapheresis Products Market, By Application
9 Leukapheresis Products Market, By End User
10 Leukopaks Market
11 Geographic Analysis
12 Competitive Landscape
13 Company Profiles
- Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
- Fresenius Se & Co. KGaA
- Haemonetics Corporation
- Hemacare Corporation
- Key Biologics, LLC.
- Terumo BCT
- ALLCells, LLC.
- Stemexpress, LLC.
- Stemcell Technologies, Inc.
- Caltag Medsystems Limited
- Zenbio, Inc.
- Precision for Medicine, Inc.
- PPA Research Group, Inc.
- Bioivt
- Macopharma SA
For more information about this report visit https://www.researchandmarkets.com/research/b8k282/leukapheresis?w=4
